CapsoVision CV
NASDAQ CV
$5.97 -0.15 (-2.45%)
At close: Aug 20, 2026 · 3:00 PM UTC

CapsoVision (CV) Cost of Revenue (2024 - 2026)

CapsoVision (CV) posted Cost of Revenue of $2.0 million for Q4 2025, up 20.94% sequentially from $1.6 million in Q3 2025, and up 14.32% YoY from $1.7 million in Q4 2024.

CapsoVision (CV) Cost of Revenue (2024 - 2026) Analysis & Trends

CapsoVision has reported Cost of Revenue for 2 years, with the latest figure at $2.0 million in Q4 2025.

  • Quarterly Cost of Revenue rose 14.32% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.8 million (changed N/A YoY) and the FY2025 annual result came in at $6.4 million, up 18.63% from the prior year.
  • Cost of Revenue advanced to $2.0 million in Q4 2025 per CV's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $2.0 million in Q4 2025 and troughed at $1.3 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 199.60 Bn 194.00 Bn 7.27 Bn 5.33 Bn
2 Stryker 127.14 Bn 123.66 Bn 4.50 Bn 2.09 Bn
3 Medtronic 118.89 Bn 109.67 Bn 6.41 Bn 3.40 Bn
4 Boston Scientific 73.11 Bn 72.57 Bn 3.85 Bn 1.59 Bn
5 Edwards Lifesciences 52.03 Bn 47.78 Bn 1.35 Bn 392.40 Mn
6 Dexcom 34.31 Bn 32.36 Bn 830.00 Mn 478.40 Mn
7 GE HealthCare Technologies 33.78 Bn 31.67 Bn 2.18 Bn 2.25 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 2.57 Bn
9 Steris 23.03 Bn 22.55 Bn 684.20 Mn 808.60 Mn
10 CapsoVision 298.13 Mn 289.05 Mn 1.87 Mn 1.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.77 Mn
Jun 30, 2026 1.77 Mn
Dec 31, 2025 1.96 Mn
Dec 31, 2025 1.96 Mn
Sep 30, 2025 1.62 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 1.50 Mn
Jun 30, 2025 1.50 Mn
Dec 31, 2024 1.72 Mn
Dec 31, 2024 1.72 Mn
Sep 30, 2024 1.31 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.25 Mn
Jun 30, 2024 1.25 Mn